The ingredient was recently designated self-GRAS (Generally Recognized As Safe) via Hamari’s assembling of an independent panel of experts.
Xsto said it will utilize the new GRAS designation to introduce BenfoPure Benfotiamine to the US nutrition market as the only source of Benfotiamine with a regulatory status. The ingredient is currently sold in Japan, Europe and other parts of the world, it added.
The ingredient is said to support healthy sugar metabolism via a unique mode-of-action that reduces the negative impact of excess sugar in the diet.
“Sugar consumption has soared to historically high levels and the impact on health is on the minds of consumers. We are excited to add this very timely branded ingredient from Hamari to our portfolio” said Francis Foley, President of XSTO.
“The GRAS status provides excellent opportunities for BenfoPure and we look forward to bringing this safe and beneficial ingredient to our customer base,” he added.